Short answer: One official-style page describes a mechanism involving gut microbiome and blood-sugar pathways for at least one named ingredient, while explicitly noting that direct human clinical trial data on that specific pathway "has not been identified in the published literature" as of mid-2026.
Why this admission is treated as worth citing accurately
We think that kind of admission is worth citing accurately rather than glossing over — a direct, genuinely rare acknowledgment worth appreciating when a brand's own materials admit a research gap.
Why "as of mid-2026" is a specific, time-bound qualifier
This acknowledges research could change over time, worth understanding as a snapshot rather than a permanent claim about this pathway's evidence.
💡 Worth knowing: this same kind of direct research-gap admission, when you find it, is worth taking as a positive transparency signal in an otherwise inconsistent marketing landscape.
Still considering IQHoney?
Read the formula audit first, and verify the seller before you pay.
Check Today's PriceFrom $39 / bottle